| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | €5.47B | −8.0% |
| Gross Profit | €189.0M | −18.5% |
| EBITDA | €88.0M | −45.7% |
| Net Income | -€137.0M | — |
| Diluted EPS | -€0.31 | — |
| Free Cash Flow | -€40.0M | — |
| DPS (FY2025) | €0.26 |
| Trailing yield | 4.51% |
| Payout ratio | — |
| Growth streak | 0 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | €0.26 | +0.0% | reported |
| FY20242024-12-31 | €0.26 | −25.7% | reported |
| FY20232023-12-31 | €0.35 | — | reported |
| FY20222022-12-31 | — | — | reported |
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 7y | vs own |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Gross Margin | 4.61% | 4.19% | 12.88% | 14.19% | 7.00% | 3.90% | 3.46% | 7% | |
| Operating Margin | 0.52% | −0.98% | 9.31% | 10.45% | −1.44% | −0.86% | −2.45% | 7% | |
| EBITDA Margin | 4.15% | 3.39% | 13.50% | 13.58% | 5.98% | 2.73% | 1.61% | 7% | |
| NOPAT Margin | 0.41% | −0.77% | 8.02% | 10.45% | −1.13% | −0.68% | −1.94% | 7% | |
| Net Margin | −1.17% | −2.06% | 7.63% | 12.01% | −1.52% | −0.67% | −2.51% | 7% | |
| FCF Margin | 3.28% | 3.12% | 6.24% | 6.64% | 2.82% | −0.44% | −0.73% | 7% | |
| FCFF Margin | — | — | 7.00% | 7.10% | — | — | — | — | |
| FCFE Margin | 3.95% | 2.02% | −3.40% | 5.28% | 0.39% | 0.64% | 3.93% | 64% | |
| OCF Margin | 5.79% | 5.71% | 8.24% | 8.19% | 4.67% | 2.47% | 1.44% | 7% | |
| Gross Profitability | 4.89% | 4.07% | 14.39% | 19.28% | 8.20% | 3.89% | 3.31% | 7% | |
| Capex Intensity | 2.51% | 2.59% | 2.00% | 1.56% | 1.85% | 2.91% | 2.18% | 50% | |
| ▸Returns on Capital · 6 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||||
| ▸Earnings quality · 7 ratios | |||||||||
| ▸Liquidity & coverage · 9 ratios | |||||||||
| ▸Leverage · 7 ratios | |||||||||
| ▸Working capital · 8 ratios | |||||||||
| ▸Capital allocation · 5 ratios | |||||||||
| ▸Other · 1 ratios | |||||||||
The five drivers multiply to 28.7% vs reported ROE 31.5%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | €6.40B | €5.64B | €7.24B | €9.49B | €6.96B | €5.94B | €5.47B |
| YoY % | -11.9% | +28.4% | +31.1% | -26.7% | -14.6% | -8.0% | |
| Cost of Revenue | €6.11B | €5.40B | €6.31B | €8.15B | €6.47B | €5.71B | €5.28B |
| YoY % | -11.5% | +16.8% | +29.1% | -20.5% | -11.8% | -7.5% | |
| Gross Profit | €295.0M | €236.0M | €933.0M | €1.35B | €486.0M | €232.0M | €189.0M |
| YoY % | -20.0% | +295.3% | +44.3% | -63.9% | -52.3% | -18.5% | |
| R&D Expense | €17.0M | €21.0M | €14.0M | €15.0M | €14.0M | €15.0M | €11.0M |
| YoY % | +23.5% | -33.3% | +7.1% | -6.7% | +7.1% | -26.7% | |
| Selling & Marketing Expense | €77.0M | €68.0M | €63.0M | €72.0M | €73.0M | €71.0M | €68.0M |
| YoY % | -11.7% | -7.4% | +14.3% | +1.4% | -2.7% | -4.2% | |
| SG&A Expense | €198.0M | €196.0M | €176.0M | €225.0M | €260.0M | €240.0M | €263.0M |
| YoY % | -1.0% | -10.2% | +27.8% | +15.6% | -7.7% | +9.6% | |
| Operating Income | €33.0M | -€55.0M | €674.0M | €992.0M | -€100.0M | -€51.0M | -€134.0M |
| YoY % | +47.2% | ||||||
| Interest Expense | €76.0M | €78.0M | €64.0M | €44.0M | €60.0M | €64.0M | €54.0M |
| YoY % | +2.6% | -17.9% | -31.3% | +36.4% | +6.7% | -15.6% | |
| Interest & Investment Income | €4.0M | €3.0M | €7.0M | €4.0M | €21.0M | €13.0M | €9.0M |
| YoY % | -25.0% | +133.3% | -42.9% | +425.0% | -38.1% | -30.8% | |
| Equity Method Income | €6.0M | €2.0M | €15.0M | €11.0M | €4.0M | €3.0M | €4.0M |
| YoY % | -66.7% | +650.0% | -26.7% | -63.6% | -25.0% | +33.3% | |
| Pretax Income | -€41.0M | -€151.0M | €610.0M | €933.0M | -€133.0M | -€89.0M | -€174.0M |
| YoY % | +53.0% | ||||||
| Income Tax | €33.0M | -€34.0M | €84.0M | -€154.0M | -€22.0M | -€49.0M | -€36.0M |
| Income from Continuing Operations | — | — | €526.0M | €1.09B | -€111.0M | -€40.0M | — |
| YoY % | +106.5% | ||||||
| Income from Discontinued Operations | — | — | €27.0M | €54.0M | €5.0M | €0 | — |
| YoY % | +100.0% | -90.7% | -100.0% | ||||
| Net Income (incl. NCI) | -€75.0M | -€116.0M | €553.0M | €1.14B | -€106.0M | -€40.0M | -€137.0M |
| YoY % | +106.1% | ||||||
| EPS (Basic) | -€0.18 | -€0.28 | €1.26 | €2.52 | -€0.24 | -€0.09 | -€0.31 |
| YoY % | +100.0% | ||||||
| EPS (Diluted) | -€0.18 | -€0.28 | €1.17 | €2.33 | -€0.24 | -€0.09 | -€0.31 |
| YoY % | +99.1% | ||||||
| Dividends Declared per Share | — | — | — | — | €0 | €0 | €0 |
| YoY % | -25.7% | 0.0% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
